Amsterdam UMC

At Amsterdam UMC, clinical trials in Cardiology focus on cardiovascular diseases such as non-ST-segment elevation acute coronary syndrome. The research is aimed at improving treatment strategies and reducing bleeding risk while maintaining protection against ischemic events.

• Testing whether simpler antiplatelet treatment can lower bleeding without sacrificing heart protection
• Evaluating better approaches to balance safety and effectiveness in acute coronary care

This work supports more personalized heart disease management and helps refine everyday treatment decisions for patients with acute cardiac conditions.

Clinical studies in digestive system diseases at this site examine Crohn’s disease and ulcerative colitis, including forms that are moderately to severely active. These trials are designed to improve disease control by setting better treatment goals and measuring whether new strategies can deepen remission.

• Assessing whether healing the bowel wall more completely leads to better outcomes in Crohn’s disease
• Comparing treatment targets that combine symptom relief, biomarker improvement, and intestinal healing

The research reflects a strong focus on gastroenterology and on finding more effective ways to monitor and manage chronic intestinal inflammation.

Trials at Amsterdam UMC also explore the overlap between obesity or overweight and inflammatory bowel disease, especially in adults with moderately to severely active Crohn’s disease or ulcerative colitis. The goal is to evaluate whether combining treatments can improve disease control while also supporting weight reduction.

• Studying whether combined therapy can achieve clinical remission and weight loss at the same time
• Exploring approaches that may improve both digestive symptoms and broader metabolic health

These investigations sit at the intersection of therapeutics, digestive disease care, and metabolic research, with a practical focus on outcomes that matter to patients in daily life.